How to Buy Illumina Stock
Illumina Inc
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.
Illumina stock last closed at $77.60, up 0.65% from the previous day, and has decreased 36.94% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.12 percentage points. Illumina stock is currently +12.95% from its 52-week low of $68.70, and -50.47% from its 52-week high of $156.66.
At the moment, there are 158.4M shares of ILMN outstanding. The market capitalization of ILMN is $12.29B. In the past 24 hours, 1.53M ILMN shares were traded.
How to Buy Illumina Stock
Not sure how to invest in Illumina stock? Here's how.
- Choose where to buy Illumina stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Illumina stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Choose your method of payment and add your information.
- Research Illumina stock: The Illumina ticker symbol is ILMN. Is Illumina stock a good investment? Should you buy shares of ILMN? How do ILMN's underlying business fundamentals look? Do top analysts think Illumina is a good buy? Why has ILMN's stock price moved recently? (Hint: Our stock analysis website can help you understand if ILMN is a good stock to buy).
- Make your ILMN buy order: Decide if you will purchase ILMN shares at the current market price or use a limit order to purchase ILMN shares at a given price.
- Monitor your ILMN position: Create a watchlist to get the latest news on your new investment in Illumina stock.
Step 1: Choose where to buy Illumina stock
You need a brokerage account to access the NASDAQ market and buy ILMN stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you can invest in ILMN today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start a new trading account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on the best investment app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring money into your new investment account.
Step 4: Research Illumina stock
After you have chosen the best place to buy Illumina stock, it's critical to evaluate their stock before you invest, so you can comprehend the risk and opportunity.
Illumina shares data
Illumina Due Diligence Score
WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on ILMN's stock page.
Is ILMN stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge ILMN's true value.
Using relative valuations metrics:
- ILMN could be overvalued based on its P/B ratio of 5.18x, relative to Diagnostics & Research industry P/B ratio of 3.39x
You can access more valuation analysis on ILMN's stock here.
How do ILMN Financials look?
Pros:
- ILMN's operating cash flow of $837.00M allows it to safely service it's debt of $2.54B.
- There are more short-term assets than short-term liabilities on the ILMN balance sheet.
- There are more short-term assets than long-term liabilities on the ILMN balance sheet.
Cons:
- Total ILMN debt is higher than 5 years ago, relative to shareholder equity.
- ILMN profit margin has gone down from -25.8% to -28% in the past year.
- ILMN has a relatively high debt to equity ratio of 1.66.
- ILMN earnings of -$1.08B is not sufficient to cover its interest payments.
Is Illumina stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 12 Wall Street analysts who monitor ILMN, the consensus analyst rating on ILMN is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest ILMN Analyst Upgrades/Downgrades
Catherine Ramsey, a top 22% analyst from Baird maintains ILMN with a hold rating and lowers their ILMN price target from $127.00 to $90.00, on Mar 5, 2025.
Tejas Savant, a bottom 7% analyst from Morgan Stanley maintains ILMN with a hold rating and lowers their ILMN price target from $150.00 to $136.00, on Feb 11, 2025.
David Westenberg, a top 12% analyst from Piper Sandler maintains ILMN with a strong buy rating and raises their ILMN price target from $185.00 to $190.00, on Feb 10, 2025.
Subbu Nambi, a bottom 14% analyst from Guggenheim maintains ILMN with a strong buy rating and lowers their ILMN price target from $170.00 to $150.00, on Feb 7, 2025.
Dan Brennan, a top 24% analyst from TD Cowen maintains ILMN with a strong buy rating and raises their ILMN price target from $166.00 to $177.00, on Nov 5, 2024.
TD Cowen's Dan Brennan raised their price target on Illumina (NASDAQ: ILMN) by 6.6% from $166 to $177 on 2024/11/05. The analyst maintained their Strong Buy rating on the stock.
Illumina reported its Q3 2024 earnings.
Although the company's X orders fell short, its Service segment beat expectations, resulting in a top-line beat, Brennan told investors.
"GM and EBIT margins had healthy beats, and management's FY 2024 guide was lowered modestly with the EPS guide raised," the analyst added.
Earnings Report
For Q3 2024, Illumina reported:
- EPS of $1.14, which beat the Zacks Consensus Estimate of $0.87 and, by 145.5%, Q3 2023’s $0.33.
- Revenue of $1.08B, which beat the Zacks Consensus Estimate by 0.48% but missed, by 2%, Q3 2023’s $1.12B.
Management guided:
For Q4 2024:
- Revenue of $1.07B.
For FY 2024:
- EPS of $4.05 to $4.15.
- Revenue to decline ~3% Y/Y.
- Operating margin of 21% to 21.5%.
CEO Jacob Thaysen commented: “During Q3, the Illumina team delivered strong operating results, and revenue met our expectations.
“We are making good strides towards Illumina’s strategic goals, both in launching breakthrough innovation and in helping our customers accelerate their adoption of the NovaSeq™ X.
“The near-term macroeconomic environment remains constrained, and we are slightly lowering our 2024 revenue guidance.
“The underlying demand for Illumina’s products and applications remains strong and we are demonstrating significant progress in driving margin and earnings expansion.”
You can dive deeper into what analysts are forecasting on the Illumina stock forecast page.
ILMN Technicals
ILMN Growth Numbers
Last year, ILMN revenue was $4.37B. Over the past 5 year, ILMN's revenue has grown by 4.29% per year. This was slower than the Diagnostics & Research industry average of 9.82%.
Dig into ILMN's earnings and revenue performance here.
What are ILMN insiders up to?
Over the past year, insiders at ILMN have sold more shares than they have bought.
Carissa Rollins, SVP Chief Information Officer of ILMN, was the latest ILMN insider to sell. They sold $8,299.85 worth of ILMN shares on Apr 5, 2025.
Learn more about who owns ILMN shares here.
Does ILMN stock generate passive income?
No, Illumina doesn't provide an income stream by paying out dividends.
ILMN Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your ILMN buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount, place a limit order.
Press the Open Trade button and your broker will execute the order.
If you want additional help with buying stocks on eToro, click the helpful video below:
Step 6: Monitor your ILMN position
Now that you own some ILMN shares, you'll want to keep up with your new stock purchase.
Create a watchlist to get notified of important updates regarding your ILMN stock.
ILMN Feed
How to Buy Stock in Illumina
To reiterate, here are the 6 steps for buying Illumina stock:
- Choose where to buy Illumina stock
- Sign up for your brokerage account
- Put funds into your investment account
- Research Illumina stock
- Make your ILMN buy order
- Monitor your ILMN position
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Illumina, click the button below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.